Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Giovana N. M. Esquissato"'
Autor:
Giovana N. M. Esquissato, Omar Cléo Neves Pereira, Tais Susane Pereira, William Mário de Carvalho Nunes, Marialba Avezum Alves de Castro-Prado, Priscila Ayumi Sybuia, João Lúcio de Azevedo, Carlos Alexandre Zanutto, Gabriela de Castro‐Prado, João Alencar Pamphile, Heloá C. G. de Oliveira
Publikováno v:
Journal of Basic Microbiology. 60:380-385
Aspergillus nidulans is a fungal model organism extensively used in genetic approaches. It may reproduce sexually and asexually, with a well-defined parasexual cycle. The current paper demonstrates that the limitation of nitrogen source facilitates t
Autor:
Emmanoel V. Costa, Giovana N. M. Esquissato, Tais Susane Pereira, Paulo Cesar de Lima Nogueira, Marialba Avezum Alves de Castro-Prado
Publikováno v:
Natural Product Research. 35:1682-1685
Hydro-distilled essential oil from leaves of Xylopia laevigata was characterized by GC-MS. Twenty-seven components were identified and the oil’s major constituents comprised germacrene D, bicyclogermacrene, (E)-caryophyllene and germacrene B. The c
Autor:
P. A. S. R. Santos, Marialba Avezum Alves de Castro-Prado, Giovana N. M. Esquissato, Claudinéia Conationi da Silva Franco, Juliane Rocha de Sant'Anna, Lúcia J Rosada
Publikováno v:
Anais da Academia Brasileira de Ciências, Volume: 86, Issue: 4, Pages: 1703-1710, Published: 21 OCT 2014
Anais da Academia Brasileira de Ciências, Vol 86, Iss 4, Pp 1703-1710 (2014)
Anais da Academia Brasileira de Ciências v.86 n.4 2014
Anais da Academia Brasileira de Ciências
Academia Brasileira de Ciências (ABC)
instacron:ABC
Anais da Academia Brasileira de Ciências, Vol 86, Iss 4, Pp 1703-1710 (2014)
Anais da Academia Brasileira de Ciências v.86 n.4 2014
Anais da Academia Brasileira de Ciências
Academia Brasileira de Ciências (ABC)
instacron:ABC
Mitotic recombination is a process involved in carcinogenesis which can lead to genetic loss through the loss of heterozygosity. The recombinogenic potentials of two anticancer drugs topoisomerase I inhibitors, camptothecin (CPT) and irinotecan (CPT-